REPCF

RepliCel Life Sciences Inc. REPCF

REPCF
RepliCel Life Sciences Inc. BTAX
Biostax Corp. STAB
Statera Biopharma, Inc. DNAG
DNAPrint Genomics, Inc. PANC
Panacos Pharmaceuticals, Inc. RCAR
RenovaCare, Inc. AVXT
AVAX Technologies, Inc. HSTC
HST Global, Inc. ARNI
Arno Therapeutics, Inc. ERGO
Entia Biosciences, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode REPCF BTAX STAB DNAG PANC RCAR AVXT HSTC ARNI ERGO
6M -95.00 % -50.00 % 0.00 % -50.00 % 0.00 % 0.00 % 0.00 % -99.96 % 0.00 % 100.00 %
YTD -90.00 % -99.37 % 0.00 % 900.00 % 0.00 % 0.00 % 0.00 % -99.98 % 0.00 % 0.00 %
1Y -97.67 % -99.71 % 0.00 % 900.00 % 0.00 % 0.00 % -90.00 % -99.98 % -66.67 % 0.00 %
3Y -98.88 % -99.99 % -99.95 % 900.00 % 900.00 % -99.81 % -90.00 % -99.84 % 9 900.00 % -71.43 %
5Y -99.01 % -100.00 % -100.00 % -99.00 % 900.00 % -100.00 % -99.63 % -99.80 % -93.33 % -98.04 %
10Y -99.97 % -100.00 % -100.00 % -99.00 % 9 900.00 % -99.99 % -99.96 % -99.37 % -99.97 % -99.76 %
Depuis le début -99.94 % -100.00 % -100.00 % -100.00 % -99.99 % -99.99 % -100.00 % -100.00 % -100.00 % -99.99 %

Dividende